Free Trial

Olink Holding AB (publ) Q1 2023 Earnings Report

Olink Holding AB (publ) EPS Results

Actual EPS
-$0.11
Consensus EPS
-$0.12
Beat/Miss
Beat by +$0.01
One Year Ago EPS
N/A

Olink Holding AB (publ) Revenue Results

Actual Revenue
$27.46 million
Expected Revenue
$27.26 million
Beat/Miss
Beat by +$200.00 thousand
YoY Revenue Growth
N/A

Olink Holding AB (publ) Announcement Details

Quarter
Q1 2023
Time
N/A

Conference Call Resources

Conference Call Audio

Slide Deck

Do this Before Elon’s Reveal on January 22nd (Ad)

Elon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.

I urge you to watch this video now.

Olink Holding AB (publ) Earnings Headlines

Waystream Holding publ AB (WAYSH)
Jetpak Top Holding AB (publ) Ordinary Shares
Trump’s Secret Manhattan Project
On January 20, a whole new Manhattan Project is set to begin: Trump’s Manhattan Project. Folks, I just spent six months investigating this...and what I found is shocking.
Olink Holding AB (6XA.SG)
See More Olink Holding AB (publ) Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Olink Holding AB (publ)? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Olink Holding AB (publ) and other key companies, straight to your email.

About Olink Holding AB (publ)

Olink Holding AB (publ) (NASDAQ:OLK) develops, produces, markets, and sells biotechnological products and services for the academic, government, biopharmaceutical, biotechnology, service provider, and other institutions that focuses on life science research. The company's products include Olink Explore that consist of Explore 372 and Explore 384 for cardiovascular and metabolic, oncology, neurology, and inflammation diseases; Olink Target product line; Olink Flex, a low-plex applications and use-cases; and Olink Focus product line that consists of custom developed solutions for customers that has identified various proteins of interest or a protein signature to focus on. Its products also comprise Olink Signature Q100, a qPCR readout platform; Olink Analysis services comprising study design and consultation, sample preparation and assay execution, and data processing and QC; and data analysis and bioinformatics services. In addition, the company offers Olink normalized protein expression (NPX) data processing software, a purpose-built software that enable users to import data, perform data analysis including visualizations, and statistical modelling; and Olink Insight, a cloud platform for Olink community to accelerate proteomics. It sells its products and services through its own direct sales force in Sweden, the United States, rest of the Americas, rest of Europe, the Middle East, Africa, Japan, and internationally. The company was formerly known as Knilo HoldCo AB and changed its name to Olink Holding AB (publ) in January 2021. Olink Holding AB (publ) was founded in 2004 and is headquartered in Uppsala, Sweden.

View Olink Holding AB (publ) Profile

More Earnings Resources from MarketBeat

Upcoming Earnings